AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited, a subsidiary of the global biopharmaceutical giant AstraZeneca, is headquartered in India and operates extensively across the country. Founded in 1979, the company has established itself as a key player in the pharmaceutical industry, focusing on innovative medicines in areas such as oncology, cardiovascular, renal, and respiratory diseases.
With a commitment to research and development, AstraZeneca India has introduced a range of unique products that address unmet medical needs, enhancing patient outcomes. The company is recognised for its strong market position, driven by a robust pipeline and strategic partnerships. Notable achievements include significant contributions to the healthcare landscape in India, underscoring its role in advancing medical science and improving public health.
+14 vs industry average
AstraZeneca Pharma India Limited’s score of 52 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at AstraZeneca Pharma India Limited?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
AstraZeneca Pharma India Limited's reported carbon emissions
In 2024, AstraZeneca Pharma India Limited reported Scope 1 emissions of approximately 452,000 kg CO2e. This marks a reduction from the previous year, 2023, when Scope 1 emissions were approximately 618,000 kg CO2e. The total emissions for 2024, calculated from the available data, amount to approximately 452,000 kg CO2e, as no Scope 2 or Scope 3 emissions data is currently available. AstraZeneca Pharma India Limited is a current subsidiary of AstraZeneca PLC, which influences its climate commitments and emissions reporting. The company has not disclosed specific reduction targets or initiatives, and there are no reported climate pledges at this time. However, it is important to note that emissions data and climate strategies may be cascaded from its parent company, AstraZeneca PLC, which is actively engaged in various sustainability initiatives. Overall, AstraZeneca Pharma India Limited is working towards understanding and managing its carbon footprint, with a focus on reducing its Scope 1 emissions in alignment with broader corporate sustainability goals.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
AstraZeneca Pharma India Limited’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for AstraZeneca Pharma India Limited yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from AstraZeneca PLC
Carbon Disclosure Project
Inherited from AstraZeneca PLC
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Inherited from AstraZeneca PLC
Climate Action 100
Emissions comparison with industry peers
View similar organisations
AstraZeneca Pharma India Limited
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project